Clinical Trial Update: AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC

View source ↗

Summary

This clinical trial update reports on AURORAX-0087A, a study evaluating glycosaminoglycan (GAG) scores for surveillance of recurrence in non-metastatic clear ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Snippet

Sponsor: Elypta | Conditions: Clear Cell Renal Cell Carcinoma | Status: COMPLETED